共 44 条
[1]
Antoni CE, 2002, ARTHRITIS RHEUM-US, V46, pS76
[2]
Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis
[J].
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH,
2002, 47 (06)
:582-587
[3]
Band DA, 1997, J RHEUMATOL, V24, P2381
[4]
Ankylosing spondylitis: what is the cost to society, and can it be reduced?
[J].
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY,
2002, 16 (04)
:691-705
[6]
Boonen A, 2001, J RHEUMATOL, V28, P1056
[7]
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis -: An open, observational, extension study of a three-month, randomized, placebo-controlled trial
[J].
ARTHRITIS AND RHEUMATISM,
2003, 48 (08)
:2224-2233
[8]
Braun J, 2002, ANN RHEUM DIS, V61, P51
[10]
Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.3.CO